Results 291 to 300 of about 365,960 (349)

Impact of real-time glucose monitoring using FreeStyle Libre 3 on glycaemia in type 2 diabetes managed with basal insulin plus SGLT2 inhibitor and/or GLP-1 agonist: the FreeDM2 randomised controlled trial protocol. [PDF]

BMJ Open
Wilmot EG, Ajjan RA, Cheah YS, Choudhary P, Cranston I, Elliott RA, Evans M, Iqbal A, Kamaruddin S, Barnard-Kelly K, Lumb A, Min T, Moore P, Narendran P, Neupane S, Rayman G, Sathyapalan T, Thabit H, Yates T, Leelarathna L.   +19 more
europepmc   +1 more source

Cytokine-mediated inflammation is independently associated with insulin sensitivity measured by the euglycemic insulin clamp in a community-based cohort of elderly men.

, 2011
Samar Basu, Björn Zethelius, Johanna Helmersson, Christian Berne, Anders Larsson, Johan Ärnlöv   +5 more
openalex   +1 more source

Beta-Hydroxybutyrate Promotes Basal Insulin Secretion While Decreasing Glucagon Secretion in Mouse and Human Islets.

Endocrinology
Banerjee R, Zhu Y, Brownrigg GP, Moravcova R, Rogalski JC, Foster LJ, Johnson JD, Kolic J.   +7 more
europepmc   +1 more source

Effectiveness and Safety of the TRIO Optimal Health Management Program in Patients With Type 2 Diabetes Mellitus Initiating Basal Insulin Therapy: Prospective Observational Real-World Study.

J Med Internet Res
Li C, Guo L, Shi L, Chen L, Chen L, Xue Y, Li H, Liang Y, Yang J, Wang W, Zhu D.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Basal insulin therapy

Current Diabetes Reports, 2004
The initiation of insulin therapy is a significant event for patients with diabetes and the physicians who care for them. Reluctance to begin insulin is multifactorial, with a major stumbling block being the perceived complexity of insulin. However, this complexity can be easily overcome by separation of insulin administration into its two components ...
John N, Clore, Linda, Thurby-Hay
openaire   +2 more sources

Insulin Glargine: A New Basal Insulin

The Annals of Pharmacotherapy, 2002
OBJECTIVE: To review the pharmacology, pharmacokinetics, dosing guidelines, adverse effects, drug interactions, and clinical efficacy of insulin glargine. DATA SOURCES: Primary and review articles regarding insulin glargine were identified by MEDLINE search (1966–July 2001); abstracts were identified through Institute for Scientific Information Web of ...
Terri L, Levien, Danial E, Baker, John R, White, R Keith, Campbell   +3 more
openaire   +2 more sources